Amber Implants Commenced clinical Trial with VCFix

Amber Implants, a cutting-edge medical technology firm producing next-generation spinal implants, has announced the formal commencement of clinical trials for the VCFix Spinal System. This first-in-human clinical trial will evaluate the safety and...

Alembic Pharma Secures Six FDA Approvals

Alembic Pharmaceuticals Limited stated that six of its abbreviated new drug applications (ANDA) were approved by the US Food and Drug Administration (US FDA) during Q2FY24. The company has received six...

Sanofi Ink Deals with Janssen To Develop E.coil

Sanofi has announced a deal with Janssen Pharmaceuticals, Inc, a Johnson & Johnson business, to develop and commercialize Janssen's vaccine candidate for extraintestinal pathogenic E. coli (9-valent), which is now in phase 3. The deal combines...

Strides Pharma Secures USFDA Nod For triglyceride Tamer Icosapent

Strides Pharma Science Ltd said that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has gained US Food and Drug Administration (USFDA) certification for its icosapent ethyl capsules in both 0.5 gram and 1 gram forms. High...

Katalin Kariko, Drew Weissman Secures Nobel Prize For Medicine

Katalin Kariko and Drew Weissman were awarded the Nobel Prize in Medicine for their work on messenger RNA (mRNA) technology, which cleared the door for the ground-breaking Covid-19 vaccines. The pair, who had been tipped as favourites...

EMA Approves Geron's MAA For Imetelstat To Treat Myelodysplastic syndromes

Geron Corporation, a late-stage clinical biopharmaceutical company, announced that the European Medicines Agency (EMA) has approved imetelstat, a first-in-class investigational telomerase inhibitor, for the treatment of transfusion-dependent...

Biogen's Tofidence Bags US FDA Approval To Treat Rheumatoid Arthritis

Tofidence (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing Actemra, has been authorized by the US Food and Drug Administration (FDA). The intravenous formulation of Tofidence has been authorized for the...

IQuest Enterprises To Acquire Active Pharma

IQuest Enterprises, a multi-sector investment group, will purchase Viatris' active pharmaceutical ingredients (API) business in India for an undisclosed sum. As per IQuest Enterprises, the investment firm has entered into a binding deal to acquire...

Novo, Torrent To Expand Partnership

As per top corporate executive, Novo Nordisk India Pvt. Ltd, the local affiliate of Danish pharmaceutical multinational Novo Nordisk, is in early talks with Torrent Pharmaceuticals Ltd to expand their manufacturing relationship...

SGC & HitGen Sign Research collaboration For Drug Discovery

HitGen Inc. established a collaboration with The Structural Genomics Consortium (SGC), a public-private partnership dedicated to the development of novel therapeutics through open-access research. HitGen will evaluate under-represented targets...

© 2025 India Pharma Outlook. All Rights Reserved.